Department of Otolaryngology and Communication Sciences, Medical College of Wisconsin, Milwaukee, Wisconsin, U.S.A.
The Institute for Health and Equity, Division of Biostatistics, Medical College of Wisconsin, Milwaukee, Wisconsin, U.S.A.
Laryngoscope. 2023 Aug;133(8):1927-1932. doi: 10.1002/lary.30421. Epub 2022 Oct 5.
Mean nocturnal baseline impedance (MNBI) is a measure of the esophageal epithelial barrier function calculated via high-resolution impedance manometry and can be used as a diagnostic tool and treatment response predictor for gastroesophageal reflux disease (GERD). However, its utility for laryngopharyngeal reflux (LPR) has been minimally studied. We aimed to investigate the relationship of MNBI between patients with suspected LPR, healthy controls, and their 24-h multichannel intraluminal impedance-pH (MII-pH) study results.
Retrospective patient series analysis was performed of patients with suspected LPR and healthy controls who underwent 24-h MII-pH monitoring. MNBI values were calculated from impedance channels at the level of the hypopharynx, proximal esophagus, and distal esophagus. We compared these MNBI values between the subject groups with secondary analysis on MII-pH results, reflux symptom index, reflux findings score, DeMeester score, and salivary pepsin levels.
Twenty-three patients with suspected LPR and 14 healthy controls were enrolled. Decreased distal esophageal MNBI was found to be significantly decreased in patients with suspected LPR compared with healthy controls (p < 0.01) and in subjects with positive MII-pH studies compared to negative MII-pH studies (p < 0.01). There were no significant correlations of MNBI at the hypopharynx or proximal esophagus.
Distal esophageal MNBI has significant correlations with many phenotypic and biological markers of LPR. These findings indicate that MNBI has the potential to be applied to LPR, similar to its emerging use as a diagnostic tool and treatment response predictor for GERD.
3 Laryngoscope, 133:1927-1932, 2023.
平均夜间基础阻抗(MNBI)是通过高分辨率阻抗测压法计算得出的食管上皮屏障功能的一种测量方法,可作为胃食管反流病(GERD)的诊断工具和治疗反应预测指标。然而,其在喉咽反流(LPR)中的应用研究甚少。本研究旨在探讨疑似 LPR 患者、健康对照者以及他们的 24 小时多通道腔内阻抗-pH(MII-pH)研究结果之间 MNBI 的关系。
对接受 24 小时 MII-pH 监测的疑似 LPR 患者和健康对照者进行回顾性病例系列分析。MNBI 值是通过咽下段、食管近端和食管远端的阻抗通道计算得出的。我们比较了这些 MNBI 值在受试组之间的差异,并进行了 MII-pH 结果、反流症状指数、反流发现评分、DeMeester 评分和唾液胃蛋白酶水平的二次分析。
共纳入 23 例疑似 LPR 患者和 14 例健康对照者。与健康对照组相比,疑似 LPR 患者的食管远端 MNBI 显著降低(p<0.01),且阳性 MII-pH 研究患者的 MNBI 显著低于阴性 MII-pH 研究患者(p<0.01)。咽下段和食管近端的 MNBI 无显著相关性。
食管远端 MNBI 与 LPR 的许多表型和生物学标志物显著相关。这些发现表明,MNBI 有可能应用于 LPR,类似于其作为 GERD 的诊断工具和治疗反应预测指标的新兴应用。
3 级喉镜,133:1927-1932,2023 年。